These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 7894496
1. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, Cosma G, Caporaso NE. Pharmacogenetics; 1994 Oct; 4(5):242-6. PubMed ID: 7894496 [Abstract] [Full Text] [Related]
2. CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy. Landi MT, Bergen AW, Baccarelli A, Patterson DG, Grassman J, Ter-Minassian M, Mocarelli P, Caporaso N, Masten SA, Pesatori AC, Pittman GS, Bell DA. Toxicology; 2005 Feb 14; 207(2):191-202. PubMed ID: 15596250 [Abstract] [Full Text] [Related]
3. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. van Duursen MB, Sanderson JT, van den Berg M. Toxicol Sci; 2005 May 14; 85(1):703-12. PubMed ID: 15659568 [Abstract] [Full Text] [Related]
4. Potentiation of CYP1A1 gene expression in MCF-7 human breast cancer cells cotreated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 12-O-tetradecanoylphorbol-13-acetate. Moore M, Narasimhan TR, Steinberg MA, Wang X, Safe S. Arch Biochem Biophys; 1993 Sep 14; 305(2):483-8. PubMed ID: 8396892 [Abstract] [Full Text] [Related]
11. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities. Vogel C, Donat S, Döhr O, Kremer J, Esser C, Roller M, Abel J. Arch Toxicol; 1997 Sep 14; 71(6):372-82. PubMed ID: 9195019 [Abstract] [Full Text] [Related]
12. Cell-specific differences in the susceptibility of potential cellular targets of human origin derived from blood and lung following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Lang DS, Becker S, Devlin RB, Koren HS. Cell Biol Toxicol; 1998 Feb 14; 14(1):23-38. PubMed ID: 9538942 [Abstract] [Full Text] [Related]
14. Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium. Bofinger DP, Feng L, Chi LH, Love J, Stephen FD, Sutter TR, Osteen KG, Costich TG, Batt RE, Koury ST, Olson JR. Toxicol Sci; 2001 Aug 14; 62(2):299-314. PubMed ID: 11452143 [Abstract] [Full Text] [Related]
15. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells. Döhr O, Vogel C, Abel J. Arch Biochem Biophys; 1995 Aug 20; 321(2):405-12. PubMed ID: 7646066 [Abstract] [Full Text] [Related]
16. Expression of 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P4501A1 in human splenic lymphocyte cultures. Jeong HG, Yang KH. Cancer Lett; 1996 Jan 02; 98(2):193-8. PubMed ID: 8556708 [Abstract] [Full Text] [Related]
17. Estradiol enhances and estriol inhibits the expression of CYP1A1 induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in a mouse ovarian cancer cell line. Son DS, Roby KF, Rozman KK, Terranova PF. Toxicology; 2002 Jul 15; 176(3):229-43. PubMed ID: 12093619 [Abstract] [Full Text] [Related]